RAELYN PLAUCHE: Open Payments
NPI 1629604129 · SORRENTO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 33 payments from 10 companies in 2025. Trend: 2023 $55 · 2024 $346 · 2025 $1,683
Food & beverage: $1,683
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $318 |
| Otsuka America Pharmaceutical, Inc. | 4 | $281 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $253 |
| Indivior Inc. | 6 | $181 |
| E.R. Squibb & Sons, L.L.C. | 5 | $180 |
| ABBVIE INC. | 2 | $148 |
| Braeburn Inc. | 2 | $140 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Alkermes, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA, SUBLOCADE, COBENFY, VRAYLAR, BRIXADI, FANAPT.
Industry payments across LA — which companies pay providers there.
